705 related articles for article (PubMed ID: 31222852)
1. Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.
Vaughan HJ; Green JJ; Tzeng SY
Adv Mater; 2020 Apr; 32(13):e1901081. PubMed ID: 31222852
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
Li J; Wang Y; Zhu Y; Oupický D
J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
[TBL] [Abstract][Full Text] [Related]
3. Glycosylated carriers for cell-selective and nuclear delivery of nucleic acids.
Wijagkanalan W; Kawakami S; Hashida M
Front Biosci (Landmark Ed); 2011 Jun; 16(8):2970-87. PubMed ID: 21622215
[TBL] [Abstract][Full Text] [Related]
4. Nucleic Acids-based Nanotherapeutics Crossing the Blood Brain Barrier.
Nafee N; Gouda N
Curr Gene Ther; 2017; 17(2):154-169. PubMed ID: 28494740
[TBL] [Abstract][Full Text] [Related]
5. Non-viral Delivery Systems for Breast Cancer Gene Therapy.
Vaseghi G; Rafiee L; Javanmard SH
Curr Gene Ther; 2017; 17(2):147-153. PubMed ID: 28595562
[TBL] [Abstract][Full Text] [Related]
6. Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
Qiu M; Glass Z; Xu Q
Biomacromolecules; 2019 Sep; 20(9):3333-3339. PubMed ID: 31342740
[TBL] [Abstract][Full Text] [Related]
7. Lipid Nanoparticles as Potential Gene Therapeutic Delivery Systems for Oral Administration.
Dorraj G; Carreras JJ; Nunez H; Abushammala I; Melero A
Curr Gene Ther; 2017; 17(2):89-104. PubMed ID: 28494737
[TBL] [Abstract][Full Text] [Related]
8. Gene Delivery Particle Engineering Strategies for Shape-dependent Targeting of Cells and Tissues.
Kozielski KL; Sitti M
Curr Gene Ther; 2017; 17(2):80-88. PubMed ID: 28494739
[TBL] [Abstract][Full Text] [Related]
9. Non-viral nucleic acid containing nanoparticles as cancer therapeutics.
Kozielski KL; Rui Y; Green JJ
Expert Opin Drug Deliv; 2016 Oct; 13(10):1475-87. PubMed ID: 27248202
[TBL] [Abstract][Full Text] [Related]
10. Towards safe nanoparticle technologies for nucleic acid therapeutics.
Miller AD
Tumori; 2008; 94(2):234-45. PubMed ID: 18564612
[TBL] [Abstract][Full Text] [Related]
11. Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.
Sunshine JC; Bishop CJ; Green JJ
Ther Deliv; 2011 Apr; 2(4):493-521. PubMed ID: 22826857
[TBL] [Abstract][Full Text] [Related]
12. Peptides for nucleic acid delivery.
Lehto T; Ezzat K; Wood MJA; El Andaloussi S
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
[TBL] [Abstract][Full Text] [Related]
13. Nonviral approaches for neuronal delivery of nucleic acids.
Bergen JM; Park IK; Horner PJ; Pun SH
Pharm Res; 2008 May; 25(5):983-98. PubMed ID: 17932730
[TBL] [Abstract][Full Text] [Related]
14. Non-viral nucleic acid delivery: key challenges and future directions.
Elsabahy M; Nazarali A; Foldvari M
Curr Drug Deliv; 2011 May; 8(3):235-44. PubMed ID: 21291381
[TBL] [Abstract][Full Text] [Related]
15. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
16. Assessing Nucleic Acid: Cationic Nanoparticle Interaction for Gene Delivery.
Singh M
Methods Mol Biol; 2021; 2211():43-55. PubMed ID: 33336269
[TBL] [Abstract][Full Text] [Related]
17. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
Castillo RR; Baeza A; Vallet-Regí M
Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
[TBL] [Abstract][Full Text] [Related]
18. Oral nucleic acid therapy using multicompartmental delivery systems.
Attarwala H; Han M; Kim J; Amiji M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28544521
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.
Kuruba R; Wilson A; Gao X; Li S
AAPS J; 2009 Mar; 11(1):23-30. PubMed ID: 19132538
[TBL] [Abstract][Full Text] [Related]
20. Extracellular targeting of synthetic therapeutic nucleic acid formulations.
Philipp A; Meyer M; Wagner E
Curr Gene Ther; 2008 Oct; 8(5):324-34. PubMed ID: 18855630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
